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SUMMARY
A rapid test based on an immunochromatography assay - Determine Syphilis TP (Abbott Lab.) for detecting specific antibodies
to Treponema pallidum was evaluated against serum samples from patients with clinical, epidemiological and serological diagnosis of
syphilis, patients with sexually transmitted disease other than syphilis, and individuals with negative serology for syphilis. The
Determine test presented the sensitivity of 93.6%, specificity of 92.5%, and positive predictive value and negative predictive value
of 95.2% and 93.7%, respectively. One serum sample from patient with recent latent syphilis showed a prozone reaction. DetermineTM
is a rapid assay, highly specific and easy to perform. This technique obviates the need of equipment and its diagnostic features
demonstrate that it may be applicable as an alternative assay for syphilis screening under some emergency conditions or for patients
living in remote localities.
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INTRODUCTION
Definitive diagnosis of syphilis has been difficult because of the
inability to cultivate Treponema pallidum subsp. pallidum in vitro.
Serological tests are pivotal for laboratory screening and diagnosis of
syphilis, and they fall into two categories: non-treponemal and treponemal
tests. The former detect cardiolipin antibodies and include Venereal
Disease Research Laboratory (VDRL) and Rapid Plasm Reagin (RPR)
tests, and both are used as screening test for syphilis as well as for
treatment follow up. However, the specificity of these cardiolipin - based
tests is not very high, therefore nonspecific reactions are observed in
some clinical or physiological conditions. Moreover, the sensibility is
lower at initial stage of primary syphilis and late period of disease (tertiary
syphilis) in comparison with the secondary syphilis. The treponemal
tests such as FTA-abs, passive hemaglutination (TPHA) or enzyme-
linked-immunosorbent assay (ELISA) using T. pallidum antigens are
used as a confirmatory test5,11,14.
All these tests require laboratorial facility to perform, and also some
period of time to obtain results. In this context, the availability of a test
with high specificity, easy to perform with reduced operator handling
time and providing rapid result would be interesting to be used in
situations of emergency or for screening of maternal and/or newborn at
moment of delivery, mainly in cases of pregnant women who have not
screened at antenatal care follow up. This format of test may also be
useful in outpatient clinics where some patients have difficulty in
returning for further consultation.
The Rapid Plasm Reagin (RPR) “teardrop” card assay for finger-
prick blood samples developed in 60’ was the first serological test for
screening of syphilis, which could be applied in field conditions without
the conventional laboratory equipments8. DYCK et al. (1993)1 evaluated
the performance of the RPR “teardrop” test with plasma obtained from
finger-prick of 466 pregnant women, and the authors observed lower
diagnostic features of the RPR “teardrop” test in comparison to the
classical RPR performed with serum.
There are several other rapid tests using cardiolipin3 or treponemal6,15
antigens, including a latex agglutination test using a purified Treponema
pallidum antigen6 or recombinant antigen15, and a DOT assay using
cardiolipin as antigen and revealed with protein A complexed with
colloidal gold3. The results of latex test are obtained in 10 minutes using
automated system or in two minutes for DOT assay, and it has been
reported3 that they provide reliable diagnostic performance, but they
have not yet been commercially available in our country.
Recently, a new test kit DetermineTM (Abbott Diagnostic, Chicago,
IL, USA) for diagnosis of syphilis was introduced on the market. This is
an immunochromatographic-based rapid test using treponemal antigen,
which does not require any equipment and the result can be obtained in
15 minutes.
In the present study, we report the diagnostic performance of the
test kit DetermineTM in the study of serum samples from patients with
syphilis, patients with sexually transmitted disease (STD) other than
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syphilis, seronegative individuals in syphilis serology assays, and
clinically healthy individuals.
MATERIAL AND METHODS
Serum samples: A total of 125 serum samples were studied,
comprising: 63 serum samples from patients with clinical, epidemiological
and laboratorial diagnosis of syphilis; 24 samples from patients with STD
other than syphilis, including cancre (2), gonorrhea (4), non-gonorrheal
ulcer (4), condiloma (10), herpes (1), candidiasis (2) and trichomoniasis
(1); 38 serum samples presenting negative results by serological tests for
syphilis. Serum samples from patients with syphilis and from patients
with STD other than syphilis were collected from individuals who were
referred to the Department of Sanitary Dermatology of School of Public
Health/University of São Paulo (USP), São Paulo, SP, Brazil, after signing
the informed consent form. Serum samples presenting negative results by
serological tests for syphilis (28) were selected from diagnostic routine
work of the Department of Serology/Institute Adolfo Lutz, São Paulo, SP,
Brazil and sera from healthy blood donors (10) who were referred to the
Pro-Sangue Foundation (Blood Bank) of São Paulo/Faculty of Medicine/
University of São Paulo.
Serological tests for syphilis: For establishing the serological status
for syphilis, serum samples were analyzed by means of the following
tests: VDRL (Behring, Marburg, Germany); FTA-abs (Wama
Diagnostica, São Carlos, SP, Brazil); TPHA (Organon-Teknika, Akzo
Nobel, Boxtel, Netherland); Captia Syphilis-M (Centocor, Malvern, PA,
USA); ELISA IgA, IgM and IgG for syphilis (Randox Laboratories,
Creemlin, UK). All of the assays were performed according to the
respective manufacture’s recommendations.
DetermineTM Syphilis TP (Abbott Diagnostic, Chicago-IL, USA.):
a qualitative assay for detecting anti-Treponema pallidum antibodies is
based on an immunochromatography technique, and its reagent kit is
presented in format of cards for individual testing. The inert solid support
is divided into three regions: region 1, with an absorbent support for
sample application (sample pad); region 2, corresponding to the sample
result display (patient window site); and region 3, corresponding to the
control reaction (control window site). Sample is added to the sample
pad, which contains the red colored complex, that is, T. pallidum antigen-
selenium colloid conjugate. This mixture migrates through the solid phase
to the immobilized Treponema pallidum antigens at the patient window
site, and moving towards to the control window site.
If anti-treponemal antibodies are present in the sample, the antibodies
bind to the Treponema pallidum antigen – selenium colloid conjugate
and to the T. pallidum antigen immobilized at the region 2, forming a
red line at the patient window site. The excess of free antigen-selenium
colloid conjugate continues migrating to the region 3 where the red line
corresponding to the control is formed. If anti-treponemal antibodies
are absent in the sample, the T. pallidum antigen-selenium colloid flows
past the region 2, and in this case the red line is formed only in the
control window (region 3). The presence of red line at control window
is essential for assay validity. Thus, the presence of red line at regions 2
and 3 in the patient and control windows, indicates positive result, while
the presence of red line at region 3 (control window) only indicates a
negative result. The assay is considered invalid in absence of red line at
control window.
For conducting the present study, the test was performed according
to the manufacture’s recommendations. Briefly, 50 µL of neat undiluted
serum was applied to the sample pad, marked by the arrow symbol. The
results were read within 15 minutes and repeated after 24 hours by five
technicians in a double-blind manner. The parameters of sensibility,
specificity and efficiency were calculated according to procedures
described by GALEN & GAMBINO2 (1975), and 95% confidence
interval (CI) according to the method described by ROTHMAN &
BOICE9 (1982).
RESULTS AND DISCUSSION
None of 125 serum samples analyzed in this study presented a “not
valid” result by the DetermineTM test. The assay yielded rapid results, it
was easy to perform without any specialized equipment. However
depending on the samples, the result interpretation was not easy due to
the personal subjectivity. According to the criteria established by
manufacturer, the presence of any red line, irrespective of its intensity
even being faint, is considered as positive reaction. Thus, there were
some difficulties in discriminating the reactivity of some samples by
five technicians who were conducing the assay.
Two samples which were considered weakly positive by DetermineTM
test presented negative results in 15 minutes reading, and a faint red line
after 24 hours. One of these samples (identified as PS-34) was from a
patient with clinical diagnosis of late latent syphilis, showing however
negative result by VDRL and positive result by treponemal tests (FTA-
abs, TPHA).
Another sample (identified as PS-22) from a patient with clinical
diagnosis of early latent syphilis presented positive results by VDRL
(1:32), FTA-abs, TPHA and total γ-ELISA, but negative result by IgM
capture ELISA. For better evaluation, this serum sample was diluted to
1:2 and 1:8 and analyzed again by DetermineTM test. At dilution 1:2 the
reactivity pattern was the same as undiluted sample, but strongly positive
at dilution 1:8. Therefore, the occurrence of prozone phenomenon was
detected. Prozone reaction may take place in an immunochromatography-
based assay owing to the high antibody level in the serum, and it could
result in an excess of free antibodies after generating a complex with
selenium colloidal-antigen conjugate. As free antibodies present higher
migration speed than complexed antibodies, they should be captured by
immobilized antigen located at patient window. Consequently, all of the
epitope sites of the immobilized T. pallidum antigen would be blocked,
just at the site where the complex seleniun colloid-antigen-antibody
complex would bind to produce a red colour band. Thus, in the presence
of excess of antibodies in the serum sample, the result could be interpreted
as negative, because of the absence of red color line at the sample window
site.
The sensibility limit of the DetermineTM was evaluated by OSHIRO
et al.7 (1999), and these authors performed dilutions of serum sample
with positive results for treponemal antibodies in TPLA – a latex
agglutination treponemal test (Mediace) with value of 47.1 titre unit
(TU). Positive reaction was detected in dilution up to 23.5 TU at 15 min,
19.2 TU at 30 min, 14.3 TU at 60 minutes or 24 hours. Their data suggest
that for samples with low level of antibodies, the time of 15 minutes
could be short to accomplish the migration and retention of the complex
antigen-selenium colloid-antibody in enough amount to form a visible
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red line at the sample window site. Hence, the reaction reading time
should be reconsidered during the performance of the assay, in account
of some clinical samples presenting very low level of specific antibodies
depending on disease stage.
Although sensitivity of 100% is desirable for screening tests, this
study showed a sensitivity of 93.7% for DetermineTM test (Table 1).
Analysis of CI 95% showed no significant difference between
DetermineTM and other treponemal tests (FTA-abs and TPHA) (Table 2).
Antibodies in the undiluted serum sample from patient PS-22 was not
detected by this assay and negative results were observed by every
treponemal serologic test in four other samples from patients with early
latent or late latent syphilis (Table 2).
Three serum samples from 24 patients with STD other than syphilis
showed positive results by DetermineTM test, and two of them also
presented reactivity by classical treponemal tests. The first sample from
a patient with clinical diagnosis of gonorrhoea (PS-86) presented positive
results by classical treponemal tests, but negative by ELISA-IgM and
VDRL. The second sample from a patient with herpes (PS-46) presented
positive results by TPHA and total γ-ELISA, and also by DetermineTM
test; and the third one from a patient with chancre had positive results by
DetermineTM test only. Based on these results, the specificity of the
DetermineTM test was 95.2%. False positive results for treponemal tests
are rare, however, false-positive results should be associated with viral
infection or mixed connective tissue and autoimmune disease13. The
overall concordance for DetermineTM was 94.4%; positive predictive value
and negative predictive value were 95.2% and 93.7%, respectively (Table
1).
In spite of DetermineTM assay being a rapid and easy to perform, its
result interpretation may occasionally be subjective and difficult. The
assay can be applicable as screening test in emergency conditions or in
pregnant women at delivery time who have not carried out an adequate
prenatal care, but it should be considered that the sensibility may be
lower when antibodies level is extremely high or too low.
According to the Law 774/9710 of December 20, 1999, laboratory
testing for the detection of HIV and syphilis antibodies has been
compulsory for every antenatal screening carried out at the public and
private service of health in the São Paulo State. Thus, this rapid test may
be a helpful tool for laboratory diagnosis in the attempt to break off the
transmission chain of congenital syphilis.
It is fundamental to carry out the investigation of syphilis at delivery
in pregnant women who have not been followed at antenatal care. The
conventional serological tests for syphilis are usually time consuming,
and commonly the mother and its newborn leave hospital even before
the results of serological tests are reported. A rapid test like DetermineTM
may be useful to overcome these limitations.
It is noteworthy to point towards the occurrence of prozone reaction
demonstrated in this treponemal test, in a condition of strongly reactive
serum sample. Then, initially this kind of serum sample may show an
atypical weakly reactivity, or in some occasions a negative “rough”
reaction with undiluted serum. It is well known that serum samples
containing large amount of antibodies may occasionally demonstrate a
prozone phenomenon in the nontreponemal serologic testing4,12, which
may be not perceived by an inexperient technician. Thus, in performing
the DetermineTM test, all tests with faint or atypical reaction should be
reanalyzed after diluting serum (at 1:2, 1:8 and so on), in order to obtain
the proper optimal antibody concentration, providing a detectable
reactivity.
Table 2
Comparison of Rapid test (DetermineTM – Abbott) results with classical serological tests used for screening and diagnosis
DetermineTMa FTA-absa TPHAa VDRLb
Group (n) Pos  Neg Pos Neg Pos Neg Pos Neg
Secondary Syphilis 12 12 0 10 02 11 01 10 02
Recent Latent Syphilis 28 27 01 27 01 27 01 21 07
Late Latent Syphilis 23 20 03 20 03 20 03 16 07
STD other than syphilis 24 03 21 01 23 02 22 0 24
Negative serological 38 0 38 0 38 0 38 0 38
results for syphilis
Sensibility (CI 95%)c 93.7% (84.4-97.9%) 90.5% (80.3–96.0%) 92.1% (82.3–97.0%) 74.6% (62.0–84.4%)
Specificity (CI 95%)c 95.2% (86.4-98.7%) 98.4% (91.2-100%) 96.8% (88.7-99.4%) 100% (94.0-100%)
a – treponemal assay; b- nontreponemal assay; c- ROTHMAN, K.J. & BOICE, J.D., 1982 9.
Table 1
Reactivity of Rapid Test (Determine Syphilis TP – Abbott Lab) in serum
samples from individuals with syphilis and from subjects presenting negative
results on classical antibody detecting tests for syphilis, and qualitative
parameters
Dignostic parameter  % (N / Total N)
Sensitivity 93.7 (59/63)
Specificity 95.2 (59/62)
Positive predictive value 95.2 (59/62)
Negative predictive value 93.7 (59/63)
Concordance 94.4 (118/125)
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RESUMO
Avaliação do teste rápido para a detecção de anticorpos anti-
Treponema pallidum baseado na técnica de imunocromatografia
O desempenho do teste rápido imunocromatográfico de procedência
comercial Determine Syphilis TP (Abbott Lab.) para detectar
anticorpos específicos contra antígenos treponêmicos foi avaliado com
soros de pacientes tendo diagnóstico epidemiológico, clínico e
laboratorial de sífilis, de pacientes com outras doenças sexualmente
transmissíveis e de indivíduos clinicamente sadios ou com resultados
negativos nos testes sorológicos para sífilis. Os valores de sensibilidade
e de especificidade do teste Determine foram respectivamente de 93,6%
e 95,2%, o valor preditivo positivo foi de 95,2% e o valor preditivo
negativo 93,6%. O fenômeno de prozona foi observado em uma amostra
de paciente com sífilis recente latente. O teste é de fácil e rápida execução,
sem necessidade de equipamentos e o resultado pode ser obtido em 15
minutos, que de acordo com suas características diagnósticas poderá ser
utilizado como teste alternativo de triagem em determinadas situações
de emergência ou em pacientes que vivem em locais remotos.
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